Drs Stephen Krieger and James Sumowski discuss developments in understanding and managing the cognitive deficits associated with MS. Medscape Neurology Source link
A new and novel oral therapy for multiple sclerosis, which inactivates rather than depletes B cells, has shown promising results in its first efficacy study. Medscape Medical News Source link
Dr Krieger provides a from-the-floor view of ECTRIMS 2018. Medscape Neurology Source link
New McDonald diagnostic criteria for multiple sclerosis were the focus of a debate here at the ECTRIMS 2018 congress that spilled over onto Twitter. Medscape Medical News Source link
© 2017 Worldnews Media LLC. All Rights Reserved.